Trial Profile
A PHASE 1, OPEN LABEL, NON-RANDOMIZED, MULTI-ARM, MULTI-CENTRE, PARALLEL SEQUENCE STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE AND THE DOSE LIMITING TOXICITY OF GENOPEP 1 (ISSAR 1) IN RELAPSED SOLID TUMOUR CANCER PATIENTS.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2016
Price :
$35
*